Chan Mitchell — SEC insider filings

SEC reporting owner CIK 1789335. 15 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2021-03-15 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Avalo Therapeutics, Inc. (AVTX)Director8—1 leg · 3,167 sh · $72,46110
REGENXBIO Inc. (RGNX)Chief Financial Officer6——8
Viela Bio, Inc. (VIE)Chief Financial Officer1——5

Insider filings — Chan Mitchell

FiledFormIssuerReported transactionsSource
2026-11-034REGENXBIO Inc. (RGNX)Grant/award (A): 24,305 @ $0EDGAR
2026-09-034REGENXBIO Inc. (RGNX)Tax withholding (F): 4,902 @ $9.32EDGAR
2026-05-074Avalo Therapeutics, Inc. (AVTX)Sale (S): 3,167 @ $22.88EDGAR
2026-03-314Avalo Therapeutics, Inc. (AVTX)Option exercise (M): 3,166 · Option exercise (M): 3,166 (derivative) @ $0EDGAR
2026-01-084REGENXBIO Inc. (RGNX)Grant/award (A): 73,749 @ $0 · Grant/award (A): 39,650 (derivative) @ $0EDGAR
2025-09-034REGENXBIO Inc. (RGNX)Tax withholding (F): 4,901 @ $8.93EDGAR
2025-06-184Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 20,100 (derivative) @ $0EDGAR
2025-04-014Avalo Therapeutics, Inc. (AVTX)Option exercise (M): 3,167 · Option exercise (M): 3,167 (derivative) @ $0EDGAR
2025-01-064REGENXBIO Inc. (RGNX)Grant/award (A): 62,547 (derivative) @ $0EDGAR
2024-09-184REGENXBIO Inc. (RGNX)Grant/award (A): 58,869 @ $0 · Grant/award (A): 289,362 (derivative) @ $0EDGAR
2024-08-144Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 24,600 (derivative) @ $0 · Grant/award (A): 9,500 (derivative) @ $0EDGAR
2023-12-214Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 3,334 (derivative) @ $0EDGAR
2022-06-154Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2021-12-034Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2021-03-154Viela Bio, Inc. (VIE)Disposition to issuer (D): 37,500 @ $53 · Disposition to issuer (D): 50,056 (derivative) · Disposition to issuer (D): 13,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 67,500 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1789335 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs